TY  - GEN
AU  - Harris,S I
AU  - Kuss,M
AU  - Hubbard,R C
AU  - Goldstein,J L
TI  - Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2-specific inhibitor, compared with ketorolac, naproxen, and placebo
SN  - 0149-2918
PY  - 2002///0123
KW  - Aged
KW  - Analgesics, Non-Narcotic
KW  - adverse effects
KW  - Anti-Inflammatory Agents, Non-Steroidal
KW  - Cyclooxygenase 2
KW  - Cyclooxygenase 2 Inhibitors
KW  - Cyclooxygenase Inhibitors
KW  - Double-Blind Method
KW  - Female
KW  - Gastric Mucosa
KW  - drug effects
KW  - Humans
KW  - Infusions, Parenteral
KW  - Isoenzymes
KW  - Isoxazoles
KW  - Ketorolac
KW  - Male
KW  - Membrane Proteins
KW  - Naproxen
KW  - Peptic Ulcer
KW  - chemically induced
KW  - Prostaglandin-Endoperoxide Synthases
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/s0149-2918(01)80117-x
ER  -